Featured Research

from universities, journals, and other organizations

New Delivery System May Improve Gene Therapy

Date:
December 4, 1997
Source:
Weizmann Institute Of Science
Summary:
A new delivery system developed at the Weizmann Institute may allow scientists to target new genes to a predetermined position in the cell's chromosomes. The method, described in the December issue of the Journal of Virology, may significantly improve gene therapy and other forms of genetic manipulation.

REHOVOT, ISRAEL, December 3, 1997...In the genes of an organism, as in real estate, location is key. The functioning of any gene is significantly affected by its exact placement on the chromosome.

Related Articles


However, scientists currently have no means of delivering a new gene to a predetermined location in a cell's chromosomes during genetic manipulation, such as gene therapy.

A method that may make it possible to control where new genes go has been developed by Prof. Ernest Winocour of the Molecular Genetics Department at the Weizmann Institute of Science together with post-doctoral fellow Dr. Joe Corsini and Prof. Jacov Tal of Ben-Gurion University of the Negev's School of Medicine.

The approach, described in the December issue of the Journal of Virology, may significantly improve all types of genetic manipulation in which new genes are introduced into an organism.

"The ultimate goal is to target a gene to a position where it brings the most good and causes no harm," says Winocour.

Long-lasting benefits

To carry new genes to the cells of an organism, scientists often use viruses that serve as "delivery vehicles." Before such a "vehicle," called a vector, is dispatched, researchers equip it with the gene they want it to deliver - for example, a healthy "replacement" copy for a faulty, disease-causing gene.

The vector inserts itself into the chromosomes and the newly delivered gene begins to replicate every time the cell divides.

However, all existing vectors insert themselves into chromosomes at random positions. As a result, scientists have poor control over the function of the new genes. When these genes make their home in certain positions, they will function poorly or not at all; in other positions they may be evicted from the cell altogether. Moreover, there is the risk that, in some positions, the new genes will negatively affect the neighboring DNA.

"Knowing where the genes go on the chromosomes may make it possible to develop improved gene therapy with a long-lasting effect," says Prof. Winocour.

'Single-minded' vectors

To attain this goal, Winocour and colleagues propose to use a family of viruses called parvoviruses. The striking feature of parvoviruses is their "single-mindedness": they are the only animal viruses that integrate themselves into the cell's chromosomes at unique sites.

Knowing in advance where the virus is headed gives scientists greater control over what it will do once it has inserted itself into the organism's genome.

In the new study, Winocour and colleagues studied one type of parvovirus called minute virus of mice, or MVM.

The scientists revealed the mechanism that allows MVM to zero in on a particular target site. They were then able to replicate this mechanism - which consists of signals exchanged by the virus and the chromosomes - in a model system.

"Further research needs to be done to see if our method works in laboratory animals, " says Winocour. If successful, it can have far-reaching applications in medicine and animal breeding.

Winocour notes further that this research may be extended to other parvoviruses. There are about 50 known parvoviruses, each of which might be capable of inserting itself at a specific location.

If the entire parvovirus family is harnessed, it may provide scientists with an extremely useful and versatile array of gene vectors.

A patent application for the new method has been filed by Yeda Research and Development Co., the Weizmann Institute's technology transfer arm, together with Ben-Gurion University of the Negev.

This research was supported by the German-Israeli Foundation for Scientific Research and Development (GIF). Dr. Corsini is the recipient of a postdoctoral fellowship from the Planning and Budgeting Committee of the Israel Council for Higher Education.

The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,500 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of the human condition. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high priorities.


Story Source:

The above story is based on materials provided by Weizmann Institute Of Science. Note: Materials may be edited for content and length.


Cite This Page:

Weizmann Institute Of Science. "New Delivery System May Improve Gene Therapy." ScienceDaily. ScienceDaily, 4 December 1997. <www.sciencedaily.com/releases/1997/12/971204071738.htm>.
Weizmann Institute Of Science. (1997, December 4). New Delivery System May Improve Gene Therapy. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/1997/12/971204071738.htm
Weizmann Institute Of Science. "New Delivery System May Improve Gene Therapy." ScienceDaily. www.sciencedaily.com/releases/1997/12/971204071738.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins